{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:23:50Z","timestamp":1781087030791,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1124\/jpet.110.172536","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T04:29:06Z","timestamp":1288672146000},"page":"596-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["A New Nonpeptidic Inhibitor of 14-3-3 Induces Apoptotic Cell Death in Chronic Myeloid Leukemia Sensitive or Resistant to Imatinib"],"prefix":"10.1016","volume":"336","author":[{"given":"Manuela","family":"Mancini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Corradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Petta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alessandra","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.172536_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.semcancer.2006.03.005","article-title":"14-3-3 proteins: a historic overview","volume":"16","author":"Aitken","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1124\/jpet.110.172536_bib2","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1128\/MCB.23.8.2790-2799.2003","article-title":"Caspase-dependent cleavage of c-Abl contributes to apoptosis","volume":"23","author":"Baril\u00e0","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.110.172536_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2141.2002.03708.x","article-title":"Mutation in the ATP-binding site of BCR-ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571","volume":"119","author":"Barthe","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.110.172536_bib4","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1016\/S0040-4039(03)01197-3","article-title":"Trimellitic anhydride linker (TAL)-highly orthogonal conversions of primary amines employed in the parallel synthesis of labeled carbohydrate derivatives","volume":"44","author":"Bauer","year":"2003","journal-title":"Tetrahedron Lett"},{"key":"10.1124\/jpet.110.172536_bib5","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1038\/onc.2009.47","article-title":"Bid: a Bax-like BH3 protein","volume":"27","author":"Billen","year":"2008","journal-title":"Oncogene"},{"key":"10.1124\/jpet.110.172536_bib6","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1002\/j.1460-2075.1995.tb00165.x","article-title":"Bcr and Raf form a complex in vivo via 14-3-3 proteins","volume":"14","author":"Braselmann","year":"1995","journal-title":"EMBO J"},{"key":"10.1124\/jpet.110.172536_bib7","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1111\/j.1742-4658.2005.04765.x","article-title":"BCR kinase phosphorylates 14-3-3 tau on residue 233","volume":"272","author":"Clokie","year":"2005","journal-title":"FEBS J"},{"key":"10.1124\/jpet.110.172536_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1097-2765(02)00431-8","article-title":"DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes","volume":"9","author":"Costanzo","year":"2002","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.110.172536_bib9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.leu.2405064","article-title":"Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition with UO126, rapamycin and Bcl-2 inhibitor GX-15\u2013070","volume":"22","author":"Dong","year":"2008","journal-title":"Leukemia"},{"key":"10.1124\/jpet.110.172536_bib10","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.110.172536_bib11","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1124\/jpet.110.172536_bib12","doi-asserted-by":"crossref","first-page":"28882","DOI":"10.1074\/jbc.272.46.28882","article-title":"14-3-3 is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in vivo regulates Raf\/14\u20133-3 interaction","volume":"272","author":"Dubois","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.172536_bib13","doi-asserted-by":"crossref","first-page":"28706","DOI":"10.1074\/jbc.M203668200","article-title":"Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization","volume":"277","author":"Fujita","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.172536_bib14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/cdd.2009.29","article-title":"Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway","volume":"16","author":"Inoue","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1124\/jpet.110.172536_bib15","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1128\/MCB.21.18.6233-6242.2001","article-title":"Targeting the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis","volume":"21","author":"Ito","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.110.172536_bib16","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"J Phys Chem"},{"key":"10.1124\/jpet.110.172536_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/mol.63.2.276","article-title":"Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571","volume":"63","author":"Kumar","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.110.172536_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.110.172536_bib19","first-page":"101","article-title":"BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon","volume":"8","author":"Liu","year":"1993","journal-title":"Oncogene"},{"key":"10.1124\/jpet.110.172536_bib20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.leukres.2006.09.022","article-title":"Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606","volume":"31","author":"Mancini","year":"2007","journal-title":"Leuk Res"},{"key":"10.1124\/jpet.110.172536_bib21","first-page":"359","article-title":"P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes","volume":"9","author":"Mancini","year":"2005","journal-title":"Gene Ther Mol Biol"},{"key":"10.1124\/jpet.110.172536_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1600-0854.2009.00897.x","article-title":"14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia","volume":"10","author":"Mancini","year":"2009","journal-title":"Traffic"},{"key":"10.1124\/jpet.110.172536_bib23","first-page":"7587","article-title":"A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins","volume":"13","author":"McWhirter","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.110.172536_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jcc.540110405","article-title":"Macromodel-an integrated software system for modeling organic and bioorganic molecules using molecular mechanics","volume":"11","author":"Mohamadi","year":"1990","journal-title":"J Comput Chem"},{"key":"10.1124\/jpet.110.172536_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0898-6568(99)00021-2","article-title":"Tyrosine phosphorylation enhances SH2 domain-binding activity of Bcr and inhibits Bcr interaction with 14-3-3 proteins","volume":"11","author":"Peters","year":"1999","journal-title":"Cell Signal"},{"key":"10.1124\/jpet.110.172536_bib26","doi-asserted-by":"crossref","first-page":"21639","DOI":"10.1074\/jbc.M203167200","article-title":"Identification of 14-3-3\u03b6 as a protein kinase B\/Akt substrate","volume":"277","author":"Powell","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.172536_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1242\/jcs.024653","article-title":"The PKC\u03b4-Abl complex communicates ER stress to the mitochondria\u2014an essential step in subsequent apoptosis","volume":"121","author":"Qi","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1124\/jpet.110.172536_bib28","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1074\/jbc.M413787200","article-title":"c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage","volume":"280","author":"Raina","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.172536_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1126\/science.7939633","article-title":"Association of the protein kinase c-Bcr and Bcr-Abl with proteins of the 14-3-3 family","volume":"266","author":"Reuther","year":"1994","journal-title":"Science"},{"key":"10.1124\/jpet.110.172536_bib30","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high throughput crystallography of protein-ligand complexes","volume":"60","author":"Sch\u00fcttelkopf","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/jpet.110.172536_bib31","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1200\/JCO.2005.05.531","volume":"23","author":"Soverini","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.110.172536_bib32","first-page":"3418","article-title":"c-Abl stabilizes p73 by a phosphorylation-augmented interaction","volume":"63","author":"Tsai","year":"2003","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.110.172536_bib33","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/sj.emboj.7600194","article-title":"JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins","volume":"23","author":"Tsuruta","year":"2004","journal-title":"EMBO J"},{"key":"10.1124\/jpet.110.172536_bib34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"key":"10.1124\/jpet.110.172536_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/376188a0","article-title":"Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways","volume":"376","author":"Xiao","year":"1995","journal-title":"Nature"},{"key":"10.1124\/jpet.110.172536_bib36","doi-asserted-by":"crossref","first-page":"12499","DOI":"10.1021\/bi991353h","article-title":"Isolation of high-affinity antagonist of 14-3-3 proteins by phage display","volume":"38","author":"Wang","year":"1999","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.110.172536_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1016357811882","article-title":"Further development and validation of empirical scoring functions for structure-based binding affinity prediction","volume":"16","author":"Wang","year":"2002","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/jpet.110.172536_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc2126","article-title":"Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia","volume":"7","author":"Weisberg","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.110.172536_bib39","doi-asserted-by":"crossref","first-page":"18891","DOI":"10.1074\/jbc.M500982200","article-title":"A structural basis for 14-3-3\u03c3 functional specificity","volume":"280","author":"Wilker","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.172536_bib40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/ncb1228","article-title":"JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage","volume":"7","author":"Yoshida","year":"2005","journal-title":"Nat Cell Biol"},{"key":"10.1124\/jpet.110.172536_bib41","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/21704","article-title":"p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage","volume":"399","author":"Yuan","year":"1999","journal-title":"Nature"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524462460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524462460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.172536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:25:28Z","timestamp":1740018328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524462460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0022356524462460"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.172536","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A New Nonpeptidic Inhibitor of 14-3-3 Induces Apoptotic Cell Death in Chronic Myeloid Leukemia Sensitive or Resistant to Imatinib","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.172536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}